← Back to Search

Smartphone-Based Cardiac Rehab for Cardiovascular Disease

N/A

Waitlist Available

Led By Amit J Shah, MD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Heart or heart-lung transplant

Current stable angina pectoris

Must not have

Acute systemic illness or fever

Symptomatic congestive heart failure (stage C)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 12, week 24

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if a smartphone app & regular phone calls can help deliver better cardiac rehab to eligible veterans, resulting in better outcomes & decreased hospitalization rates.

Who is the study for?

This trial is for veterans who've had a heart attack in the last year, stable chest pain, heart surgery like bypass or valve replacement, angioplasty or stenting, heart transplants, or other specific heart conditions. They must be eligible for cardiac rehab and not have uncontrolled health issues like severe diabetes or high blood pressure.

What is being tested?

The study tests if a smartphone app and phone calls can help deliver better cardiac rehabilitation at home compared to usual care. It looks at whether patients stick with the program better, manage their symptoms well, learn more about their condition, and if it reduces hospital visits.

What are the potential side effects?

Since this trial involves exercise and education through an app rather than medication, side effects are minimal but may include discomfort from new physical activities or technical issues with using the smartphone application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had a heart or heart-lung transplant.

Select...

My chest pain is stable and not worsening.

Select...

I have had a heart valve repair or replacement.

Select...

I have had a procedure to open blocked heart arteries.

Select...

I have had heart bypass surgery.

Select...

I had a heart attack in the last year.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have a fever or any sudden illness.

Select...

I have symptoms of heart failure that affect my daily activities.

Select...

I have a condition that affects blood flow to my limbs and prevents me from exercising.

Select...

I have had a recent blood clot in my veins.

Select...

I do not have active inflammation of the heart.

Select...

I do not have bone or joint problems that would stop me from exercising.

Select...

I currently have inflammation in my veins due to a blood clot.

Select...

My diabetes is not under control (A1c > 7.0).

Select...

I have unstable chest pain.

Select...

My blood pressure has dropped significantly without explanation.

Select...

I have a serious narrowing of my heart's aortic valve.

Select...

I have irregular heartbeats that are not under control.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 12, week 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 12, week 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12, week 24 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Functional Capacity assessed by the Six Minute Walk Test (6MWT)

Secondary study objectives

Change in A1c Level

Change in Blood Pressure

Change in Body Mass Index (BMI)

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Pulmonary Rehabilitation - Movn ProgramExperimental Treatment1 Intervention

Participants with stable chronic obstructive pulmonary disease (COPD) or hospitalized with an acute exacerbation of COPD will undergo an in-home pulmonary rehabilitation program.

Group II: Cardiac Rehabilitation - Movn ProgramExperimental Treatment1 Intervention

Participants with coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) who are eligible for cardiac rehabilitation will undergo an in-home program.

Group III: Traditional Cardiac RehabilitationActive Control1 Intervention

Participants enrolled in a facility's traditional cardiac rehabilitation program will be seen at baseline and during a 12 and 24 week follow-up visit.

0 / 18Eligibility criteria met